SpinChip Diagnostics AS

Carnegie Investment Bank is proud to have acted as Sole Bookrunner in connection with SpinChip Diagnostics AS’ successful NOK 65 million private placement.

SpinChip Diagnostics is a medical device company who has developed a proprietary platform focused on in-vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments. The diagnostics platform has, through internal trials, already demonstrated the ability to match the most advanced high-sensitive laboratory diagnostic analyzers, meaning it can contribute to faster reliable triaging and facilitate earlier appropriate treatment of patients. SpinChip is now preparing for clinical trial activities, including clinical performance studies, to gather sufficient data to apply for CE-marking.

Carnegie congratulates Chair Åse Aulie Michelet, CEO Morten Jurs, CSO Stig Morten Borch, the shareholders and the rest of the SpinChip team with the successful transaction. We look forward to continuing our support of SpinChip going forward.

Related articles

Nordic Nanovector
Investment Banking

Nordic Nanovector

Nordic Nanovector ASA announced 6th of June the signing of an agreement to acquire Thor Medical...

KONGSBERG Gruppen
Investment Banking

KONGSBERG Gruppen

Carnegie Investment Bank is proud to have acted as Financial Advisor to KONGSBERG Gruppen in...

BEWI Invest
Investment Banking

BEWI Invest

Carnegie Investment Bank acted as Joint Bookrunner in the NOK 643 million private placement in BEWI Invest....